Theriva Biologics Inc (TOVX)
1.30
+0.02
(+1.56%)
USD |
NYAM |
Nov 22, 09:34
Theriva Biologics Total Assets (Quarterly): 40.11M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 40.11M |
| June 30, 2024 | 42.39M |
| March 31, 2024 | 48.73M |
| December 31, 2023 | 55.22M |
| September 30, 2023 | 61.54M |
| June 30, 2023 | 65.45M |
| March 31, 2023 | 67.89M |
| December 31, 2022 | 71.86M |
| September 30, 2022 | 78.70M |
| June 30, 2022 | 82.33M |
| March 31, 2022 | 89.00M |
| December 31, 2021 | 70.36M |
| September 30, 2021 | 75.12M |
| June 30, 2021 | 77.26M |
| March 31, 2021 | 79.05M |
| December 31, 2020 | 8.41M |
| September 30, 2020 | 7.203M |
| June 30, 2020 | 9.582M |
| March 31, 2020 | 11.89M |
| December 31, 2019 | 17.24M |
| September 30, 2019 | 20.74M |
| June 30, 2019 | 24.00M |
| March 31, 2019 | 26.63M |
| December 31, 2018 | 30.14M |
| September 30, 2018 | 10.80M |
| Date | Value |
|---|---|
| June 30, 2018 | 8.418M |
| March 31, 2018 | 12.47M |
| December 31, 2017 | 18.84M |
| September 30, 2017 | 23.28M |
| June 30, 2017 | 15.74M |
| March 31, 2017 | 17.72M |
| December 31, 2016 | 22.50M |
| September 30, 2016 | 8.248M |
| June 30, 2016 | 16.33M |
| March 31, 2016 | 22.74M |
| December 31, 2015 | 30.84M |
| September 30, 2015 | 42.63M |
| June 30, 2015 | 11.84M |
| March 31, 2015 | 13.72M |
| December 31, 2014 | 19.14M |
| September 30, 2014 | 4.741M |
| June 30, 2014 | 9.289M |
| March 31, 2014 | 12.53M |
| December 31, 2013 | 16.26M |
| September 30, 2013 | 6.953M |
| June 30, 2013 | 9.627M |
| March 31, 2013 | 11.68M |
| December 31, 2012 | 13.42M |
| September 30, 2012 | 5.826M |
| June 30, 2012 | 7.245M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.203M
Minimum
Sep 2020
89.00M
Maximum
Mar 2022
52.97M
Average
63.50M
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co Inc | 117.53B |
| Pro-Dex Inc | 54.31M |
| BioCardia Inc | 6.267M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.47M |
| Shareholders Equity (Quarterly) | 24.64M |